Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details 2)

v3.20.1
STOCKHOLDERS' EQUITY (Details 2)
3 Months Ended
Mar. 31, 2020
$ / shares
shares
Equity [Abstract]  
Balance outstanding at the beginning of the period (in shares) | shares 2,310
Balance at the beginning of the period (in dollars per share) | $ / shares $ 25.84
Forfeited (in shares) | shares (16)
Forfeited (in dollars per share) | $ / shares $ 24.28
Vested (in shares) | shares (626)
Vested (in dollars per share) | $ / shares $ 19.76
Granted (in shares) | shares 572
Granted (in dollars per share) | $ / shares $ 36.73
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance | shares 2,240
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Ending Balance | $ / shares $ 30.42